29-Dec-2025
Claritev Ends Former CEO’s Strategic Advisory Role
TipRanks (Mon, 29-Dec 4:30 PM ET)
Claritev Corporation Announces Participation at Upcoming Conferences
Business Wire (Mon, 24-Nov 8:00 AM ET)
Claritev’s $77.25M Share Offering: Selling Stockholders Opt to Reduce Stake, Not Dilute Equity
Market Chameleon (Thu, 13-Nov 4:15 AM ET)
Claritev Corporation Announces Pricing of Offering of Class A Common Stock by Selling Stockholders
Business Wire (Wed, 12-Nov 11:01 PM ET)
Claritev Corporation Announces Public Offering of Class A Common Stock by Selling Stockholders
Business Wire (Wed, 12-Nov 4:10 PM ET)
Claritev Corporation Reports Third Quarter 2025 Results
Business Wire (Fri, 7-Nov 6:00 AM ET)
Business Wire (Mon, 27-Oct 5:00 PM ET)
Claritev Corporation Announces Third Quarter 2025 Earnings Conference Call
Business Wire (Thu, 16-Oct 7:00 AM ET)
Business Wire (Wed, 8-Oct 4:30 PM ET)
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
Claritev Class A trades on the NYSE stock market under the symbol CTEV.
As of December 29, 2025, CTEV stock price climbed to $42.41 with 560,503 million shares trading.
CTEV has a beta of 1.60, meaning it tends to be more sensitive to market movements. CTEV has a correlation of 0.07 to the broad based SPY ETF.
CTEV has a market cap of $700.85 million. This is considered a Small Cap stock.
Last quarter Claritev Class A reported $246 million in Revenue and -$4.23 earnings per share. This beat revenue expectation by $10 million and missed earnings estimates by -$.85.
The top ETF exchange traded funds that CTEV belongs to (by Net Assets): VTI, IWM, FNDA, VXF, IWO.
CTEV support price is $39.26 and resistance is $44.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTEV shares will trade within this expected range on the day.